JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2025-02-28 12418dafm09(暂无昵称) 来自浙江省

under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏

5 0

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2023-05-15 ms7000000363747460 来自湖南省

请问下大家Awaiting Admin Processing几天

137 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2025-01-31 1256aa6cm86暂无昵称来自陕西省

请问收基础实验的文章吗

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2021-09-02 起云

偏重的研究方向：性病
经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样

406 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2024-02-03 ms6000001766034942 来自山东省

投着投着显示面板看不见稿件任何信息了

99 0

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2023-10-31 ms3000000179629265 来自山西省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。

111 0

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2023-01-17 1256aa6cm86暂无昵称来自陕西省

11月25投稿，现在还显示Under review，不知道送外审了没

194 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2023-08-24 941739541 来自天津

偏重的研究方向：皮肤病
经验分享：请问半个月就awiting decision 是不是都没有送外审🤣

111 0

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2021-09-02 起云

偏重的研究方向：性病
经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊

337 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2254070, encodeId=407f22540e0c2, content=under review1月，awaiting recommend 3天又变成了under review 2天，然后又变成awaiting recommend 2周多了，请问要多久🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8652460850, createdName=12418dafm09(暂无昵称), createdTime=Fri Feb 28 23:19:31 CST 2025, time=2025-02-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2250061, encodeId=0e942250061ed, content=请问收基础实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Fri Jan 31 10:28:56 CST 2025, time=2025-01-31, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向：性病 经验分享：Awaiting recommendation需要多久啊，一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：审稿审了两个月，两个意见一个小修一个大修，编辑给拒了，搞不懂，给的理由是没有足够的优先级，为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿，现在还显示Under review，不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向：皮肤病 经验分享：请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向：性病 经验分享：想问一下为什么一直是Awaiting Recommendation？这个状态得多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：自身免疫性疱病 经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省)]

2023-03-28 ms9000000353253855 来自山东省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：自身免疫性疱病
经验分享：2023年3月14日投，中间经历了under review，awaiting recommendation,28号变成Awaiting Decision，。。。。。。。紧张，是不是太快了

164 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务